Features | Partner Sites | Information | LinkXpress
Sign In
Bio-Rad Diabetes Division
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.

HbA1c and Diabetic Ketoacidosis POC Analyzers to Be Demonstrated at ArabHealth

By Labmedica International staff writers
Posted on 03 Jan 2014
Image: The EKF Quo-Lab HbA1c Analyzer (Photo courtesy of EKF Diagnostics).
Image: The EKF Quo-Lab HbA1c Analyzer (Photo courtesy of EKF Diagnostics).
A leader in in-vitro diagnostics will exhibit in an upcoming medical congress two point-of-care (POC) analyzers for the rapid assessment of diabetes and related conditions.

The Quo-Lab HbA1c analyzer and the STAT-Site M β-HB by EKF Diagnostics (EKF; Cardiff, UK) will be demonstrated at the Welsh stand during the ArabHealth healthcare exhibition and medical congress, which will take place January 27–30, 2014, at the International Convention and Exhibition Center in Dubai (UAE).

HbA1c monitoring is increasingly used in the detection and management of diabetes: Quo-Lab provides highly accurate, affordable, and easy-to-use technology, which uses only 4 µL of venous or finger prick blood to deliver results within four minutes. The analyzer, which was launched mid-2013, has had a good reception, with nearly 1,300 being sold globally to date. The Quo-Lab analyzer is designed to meet the needs of GP surgeries, clinics, and laboratories in emerging economies, where diabetes has become a growing public health issue.

The second analyzer to be demonstrated, the STAT-Site M β-HB, is a quantitative strip-based test for ß-Hydroxybutyrate (ß-HB). The device provides quick and easy assessment of diabetic ketoacidosis (DKA), delivers results in less than 80 seconds, and it is CE marked.

Using the STAT-Site M ß-HB, the presence and degree of ketosis can be assessed at POC by accurately measuring blood levels of ß-HB, which accounts for 78% of the three ketone bodies, from just 10 µL of serum or plasma. This provides useful information to deliver quality care when monitoring DKA in newly diagnosed patients, while also reducing time and costs in an emergency room setting.

Related Links:

EKF Diagnostics



77 ELEKTRONIKA
PURITAN MEDICAL
DiagCor Bioscience
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel
Image: The Cobas 6000 Multipurpose Clinical Laboratory analyzer (Photo courtesy of Roche Diagnostics).

Low Density Lipoprotein Apolipoprotein-B Assay Validated

The relationship between apolipoprotein-B (Apo-B) concentration and the risk of developing cardiovascular disease (CVD) is more robust than the relationship between low density lipoprotein cholesterol... Read more

Genetic Tests

view channel
Histopathology of colonic adenocarcinoma; the glands are enlarged and filled with necrotic debris (Photo courtesy of the University of Utah).

Promising Blood Biomarkers Isolated for Colorectal Cancer

The search for blood-borne biomarkers that could be used to screen for colorectal cancer (CRC) has uncovered two promising candidates that may one day lead to the development of a simple blood test.... Read more

Microbiology

view channel

Novel Sequence Analysis Services Improve Pathogen Identification

A set of new-generation sequencing (NGS) services provides unique tools for more effective identification of known and unknown microorganisms, including bacterial, viral, fungal, and protozoan parasite pathogens. Aperiomics (Ashburn, VA, USA) has now introduced its breakthrough Absolute-NGS Pathogen Detection Platform... Read more

Industry News

view channel

Market for qPCR Exceeds USD 3 Billion

The market for real-time quantitative polymerase chain reaction (qPCR) was valued at about USD 3.2 billion for 2013 according to Kalorama Information (New York, NY, USA) an increase from USD 2.8 billion in 2011. The healthcare market researcher said that the testing system is considered the workhorse of research providing... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.